Off-label uses are neither risky nor investigational; they constitute the traditional practice of medicine that has existed long before the FDA. The off-label designation by the FDA is simply a term they use to mean they are silent on the indicated use. Medicare, medicaid, and private health insurances cover medically approved uses of HBOT only. As such, there are many other conditions that are considered “off-label” which are not covered by insurance companies.
Listed below, are some promising use of mild Hyperbaric Oxygen Therapy (mHBOT):
- Lyme disease
- Acute Coronary Syndrome (ACS)
- Alzheimer’s
- Autism
- Cerebral Palsy (CP)
- Migraine/Headaches
- Multiple Sclerosis (MS)
- Stroke
- Traumatic Brain Injury (TBI)
- Vascular Dementia (VD)
- Arthritis
- Chronic Fatigue Syndrome (CFS)
- Complex Regional Pain Syndrome (CRPS)
- Fibromyalgia
- Chemotherapy Recovery
- Cancer